acamprosate calcium 333 mg / 1 Tablet 180 Tablet, Delayed Release
Comprehensive product details for sourcing and verification.
| NDC 11 | 68382-0569-28 |
|---|---|
| Product NDC | 68382-0569 |
| Generic Drug Name | acamprosate calcium |
| Brand Name | acamprosate calcium |
| Manufacturer | Zydus Pharmaceuticals (USA) Inc. |
| Strength | 333 mg / 1 |
| Dosage Form | Tablet |
| Drug Type | Oral |
| Package Quantity | 180 Tablet, Delayed Release |
| Package Description | 180 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-28) |
| Active Ingredients | Acamprosate Calcium |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
acamprosate calcium 333 mg / 1 Tablet is tracked under NDC 68382-0569-28 and rolls up into product family 68382-0569. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 180 Tablet, Delayed Release.
- Manufacturer: Zydus Pharmaceuticals (USA) Inc..
- Dosage form: Tablet.
- Family size: 6 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Documented shortage listings have included acamprosate calcium in shortage reporting in 2015 and again in 2024, suggesting some recurring supply risk.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
acamprosate calcium 333 mg / 1 Tablet 180 Tablet, Delayed Release, NDC 68382-0569-28, is a Zydus Pharmaceuticals (USA) Inc. 333 mg / 1 tablet presentation packaged as 180 Tablet, Delayed Release. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 68382-0569-28.
- Digits-only NDC 11: 68382056928.
- Possible 10-digit display format: 68382-569-28 (6838256928).
Helpful product links
- Search by brand name: acamprosate calcium.
- Exact NDC 11: 68382-0569-28.
- Product family NDC: 68382-0569.
- Other package sizes in this family: 100 Tablet, Delayed Release, 1000 Tablet, Delayed Release, 30 Tablet, Delayed Release, 500 Tablet, Delayed Release, 90 Tablet, Delayed Release.
- Compare related presentations: acamprosate calcium 333 mg / 1 Tablet 100 Tablet, Delayed Release, acamprosate calcium 333 mg / 1 Tablet 1000 Tablet, Delayed Release, acamprosate calcium 333 mg / 1 Tablet 30 Tablet, Delayed Release, acamprosate calcium 333 mg / 1 Tablet 500 Tablet, Delayed Release, acamprosate calcium 333 mg / 1 Tablet 90 Tablet, Delayed Release.